Rock Out like It’s the 00s
    Listen Now

    Listen to Stations For You

    Change genre preferences

    Scientists have known for decades that people who've had a liver transplant need less medication to suppress their immune system and prevent their body from rejecting the organ they received. This is true even if they receive other organs along with a new liver, the study authors explained.

    .
    .
    .
    .
    ', shareTitle: "", shareDesc: "", shareImg: '/img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/news/2017/08_2017/car_t_cell_therapy/Car_T_cell_therapy_graphic.png', shareLink: 'www.webmd.com/cancer/news/20180427/new-superblood-treatment-targets-deadly-cancers' } ); });

    Expert Perspective

    "The [superblood] concept is interesting," says Brian Wolpin, MD, MPH, director of the Gastrointestinal Cancer Center and the Hale Center for Pancreatic Cancer at the Dana-Farber Cancer Institute. Further testing will need to prove whether it will have a substantial impact on the diseases it treats.

    Whether the new approach catches on will depend not only on how superior the treatment is, but also on costs, Radu of UCLA says.

    .
    http://cheapciali.top/Kurtenbach-neighbour-of-Machalek-from-Gandabara?Mattygran=100
    .
  • About
  • .